SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001005477-01-000713
Filing Date
2001-02-07
Accepted
2001-02-07 00:00:00
Documents
1
Group Members
HAROLD R. WERNERHEALTHCARE PARTNERS II, L.P.HEALTHCARE PARTNERS III, L.P.HEALTHCARE PARTNERS IV, L.P.HEALTHCARE VENTURES II LPHEALTHCARE VENTURES III, L.P.HEALTHCARE VENTURES IV, L.P.JAMES H. CAVANAUGH, PH.D.JOHN W. LITTLECHILDWILLIAM CROUSE

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13G 0001.txt SC 13G/A 38558
  Complete submission text file 0001005477-01-000713.txt   41104
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-37761 | Film No.: 1527172
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address TWIN TOWERS AT METRO PARK 379 THORNALL AVENUE EDISON NJ 08837
Business Address TWIN TOWERS AT METRO PARK 379 THORNALL AVENUE EDISON NJ 08837 9089064613
HEALTHCARE VENTURES II LP (Filed by) CIK: 0000859649 (see all company filings)

IRS No.: 223015728 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 0000